Vaccine funding types

On the vaccination encounter form, the funding type field offers three options: NIP, State Program, and Other. The option you pick tells Light where the vaccine's stock came from, and that drives which claim is prepared.

What each option means

The field records the provenance of the stock — who supplied and paid for the dose:

• NIP — funded under the National Immunisation Program (Commonwealth-supplied stock).
• State Program — supplied under a state or territory government program.
• Other — privately purchased or practice stock that isn't funded or supplied by a government program.

How the choice routes the claim

Light uses the funding type to decide which claim, if any, to prepare from the encounter:

• NIP → PPA NIPVIP claim (or CVCP for COVID-19 vaccinations given up to 30 September 2026, when the CVCP program ends). The dose is treated as Commonwealth-supplied, so the claim goes to the Commonwealth funder.
• State Program → the matching state-funded program claim, if your pharmacy is configured for one.
• Other → a state-funded program claim can still be prepared where one applies and the program accepts privately-held stock. If no program matches, no claim is prepared — the vaccination still goes to AIR, it just isn't claimable.

Recording free flu vaccines

A QLD Free Flu or NSW FluMist vaccine is free to the patient and the claim goes to the state program either way — both State Program and Other reach the program where it applies. Pick the one that matches where the dose came from: State Program if it was state-supplied stock, Other if it was your own private or practice stock.

The choice to avoid is NIP: it tells AIR the dose came from NIP supply and routes a NIPVIP claim instead of the state-program claim.

If you don't see the expected claim, check QLD Free Flu eligibility or NSW FluMist eligibility for the specific conditions that need to be met.

When a vaccine could arguably fit either

Some vaccines are funded under different programs in different contexts — influenza is under NIP for some cohorts and state-funded for others; RSV is under NIPVIP for older adults but private otherwise. The right funding type is the one that matches the stock used for this specific dose, not the vaccine product in general.

If you're unsure, the source of the dose is the tiebreaker:

• Drawn from NIP supply (patient NIP-eligible by age, cohort, Indigenous status) → NIP
• Supplied under a state or territory program → State Program
• Privately purchased or practice stock → Other

Picking the wrong one will skip the right claim or route it to the wrong funder — re-record the encounter (or amend and re-evaluate) when the mistake is caught.